Company intelligence / Profile preview

Raritan Pharmaceuticals

East Brunswick, New Jersey, United Statesraritanpharm.com ↗

Ownership: Private
Employees: ~263
Development stage: Commercial

Overview

Raritan Pharmaceuticals develops, manufactures, and markets a wide range of over-the-counter medicines and consumer healthcare products in the US. Their portfolio includes antacids, cough/cold remedies, analgesics, nutritional supplements, medical devices, and therapeutic cosmetics. The company is recognized for rapid new product introductions in the US retail market.

Therapeutic areas: GastroenterologyPulmonologyNeurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

3 assets

Homeopathic Infant's Teething Tablets

Commercial

Indications: Teething

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Raritan Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raritan Pharmaceuticals.

Explore the full profile